Vancouver, Canada – June 5, 2025 – Onco-Innovations Limited (CBOE: ONCO) (Frankfurt: W1H, WKN: A3EKSZ) ("Onco" or the "Company”) is pleased to announce that its

Vancouver, Canada – May 26, 2025 – Onco-Innovations Limited (CBOE: ONCO) (Frankfurt: W1H, WKN: A3EKSZ) ("Onco" or the "Company”) is pleased to announce that Dalton Pharma Services

Vancouver, Canada – May 26, 2025 – Onco-Innovations Limited (CBOE: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) ("Onco" or the "Company") announces, further to its news ...

Vancouver, Canada – May 22, 2025 – Onco-Innovations Limited (CBOE: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H,WKN: A3EKSZ) (“Onco” or the “Company”) is pleased to announce the appoi...

Vancouver, British Columbia – May 16, 2025 – Onco-Innovations Limited (CSE: ONCO) (“Onco” or the “Company“) is pleased to announce that it will transfer the listing of its comm...

Vancouver, Canada – April 30, 2025 – Onco-Innovations Limited (CSE: ONCO) (Frankfurt: W1H, WKN: A3EKSZ)(OTCQB: ONNVF) (“Onco” or the “Company“) is pleased to announce that it ha...